A coalition of healthcare entities looks to revamp diabetes care by cutting out traditional glucometers and lancets while providing real-time data to care providers.
In the joint venture, the Mayo Clinic, Gentag, NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems want to create low-cost, pain-free glucose monitoring through a smartphone platform that incorporates a glucometer reader via the device's near field communication technology.
The system features proprietary sensors, software, chip knowledge and involves 75 patented technologies and can be used for any diabetes application, including long-term implantable sensors, diabetes skin patches or eye (tear drop) sensors, or wireless insulin delivery systems controlled by mobile devices. Announcement